Clinically Relevant Comparative Effectiveness of Alcoholism Treatments

Published Date
CFDA
93.273
Contact Information
Cherry Lowman, 301-443-0637; clowman@mail.nih.gov
Deadline
Eligiblity
State, local and tribal governments, nonprofit, for-profit and tribal organizations, and institutions of higher education
Guide Page Reference
None
Program Area
Programe Purpose
To support research on the comparative effectiveness in typical clinical settings of pharmacologic and behavioral treatments for alcohol use disorders given patient characteristics, and the organizational, financial and management factors that facilitate or inhibit the delivery of evidence-based services for alcohol use disorders